In 1996, we described a 3 generation VHL 2A kindred with 11 mutation carriers. We aim to share our experience regarding the long-term follow-up of this family
PatientID: 1
KindredID: 1
Case: F, 71Y0M, Ethnicity Unknown
DiseaseAssertion: VHL
FamilyInfo: This patient was a member of family 1, where 14/32 total patients were diagnosed with VHL. One of which (I-32) was a mutational carrier with down syndrome. The other 13 patients had varying phenotypes, including adrenal pheochromocytoma, pancreatic endocrine tumors, liver and bone metastases, paraganglioma, cerebellar, spinal, and retinal hemangioblastomas, polycythemia, and chondrosarcoma. See Fig. 1 for family pedigree.
CasePresentingHPOs: HP:0006748; HP:0030405 (adrenal pheochromocytoma; pancreatic endocrine tumor)
CaseHPOFreeText: Patient presented with his initial VHL-related clinical manifestations at 34Y0M. She was found to have adrenal pheochromocytoma and a pancreatic endocrine tumor. She underwent a bilateral adrenalectomy, as well as a hemapectomy due to liver metastases. Patient diagnosed with VHL subtype 2A at 68Y0M and passed away at age 71Y0M (see table 1).
CaseNotHPOs: HP:0002668; HP:0010797 (paraganglioma, hemangioblastoma)
CaseNotHPOFreeText: He did not have paraganglioma or hemangioblastoma.
CasePreviousTesting: N/A
PreviouslyPublished: 8550742
SupplementalData: N/A
Variant: p.V166F (c.496G>T)
LegacyVariant: N/A
CaseProblemVariantFreeText: N/A
ClinVarID: 2224, https://www.ncbi.nlm.nih.gov/clinvar/variation/2224/
CAID: N/A
gnomAD: N/A
VariantEvidence: N/A
MutationType: missense_variant; transversion
CivicName: V166F (c.496G>T)
MultipleGeneVariants: N/A